Medicine
Volume 37, Issue 9 , Pages 445-449, September 2009

Testosterone replacement therapy

Leighton J Seal PhD FRCP is a consultant and Honorary Senior Lecturer in Endocrinology and Diabetes at St George's Hospital, Tooting and also Consultant Endocrinologist at the Gender Identity Clinic at Charing Cross Hospital, London, UK. Competing interests: The author has been a speaker for Bayer Schering Pharmaceuticals and received fees for consulting for that company

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1357-3039(09)00182-0

doi:10.1016/j.mpmed.2009.06.002

Medicine
Volume 37, Issue 9 , Pages 445-449, September 2009

Article Tools